RBC Capital Markets reveals its 2023 biotech favourites
The biotech sector has shown signs of recovery in recent months, driven in part by favourable commercial performance and clinical readouts, according to RBC...
Source: proactiveinvestors.com
Page 18 - Morphic Holding News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Morphic Holding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Morphic Holding Today - Breaking & Trending Today
RBC Capital Markets reveals its 2023 biotech favourites
The biotech sector has shown signs of recovery in recent months, driven in part by favourable commercial performance and clinical readouts, according to RBC...
Source: proactiveinvestors.co.uk
Morphic : Announces Corporate Highlights and Financial Results for the Second Quarter 2022 - Form 8-K
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2022 Continued enrollment of EMERALD-1 phase 2a trial of MORF-057 in... | August 3, 2022
Source: marketscreener.com
Morphic Holding, Inc. (NASDAQ:MORF) Given Average Rating of "Buy" by Brokerages
Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) has earned an average rating of “Buy” from the seven brokerages that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price target among brokerages that […]
Source: etfdailynews.com
Morphic Announces Participation In Cowen 42nd Annual Healthcare Conference
WALTHAM, Mass., March 04, 2022 -- Morphic Therapeutic , a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today... | March 4, 2022
Source: marketscreener.com